SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-007731
Filing Date
2021-11-09
Accepted
2021-11-09 12:53:07
Documents
47
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20210930_10q.htm   iXBRL 10-Q 798202
2 EXHIBIT 31.1 ex_302708.htm EX-31.1 7497
3 EXHIBIT 31.2 ex_302709.htm EX-31.2 7435
4 EXHIBIT 32.1 ex_302710.htm EX-32.1 5246
  Complete submission text file 0001171843-21-007731.txt   3644792

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20210930.xsd EX-101.SCH 30015
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20210930_cal.xml EX-101.CAL 29038
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20210930_def.xml EX-101.DEF 234064
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20210930_lab.xml EX-101.LAB 211784
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20210930_pre.xml EX-101.PRE 251335
10 EXTRACTED XBRL INSTANCE DOCUMENT xbit20210930_10q_htm.xml XML 493486
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 211391109
SIC: 2834 Pharmaceutical Preparations